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High levels of psychological distress are documented in patients with COPD. This study investigates the
extent to which patients with a high score on the Hopkins Symptoms Checklist-25 (HSCL-25) or with a high
score on the Mental State scale of the Clinical COPD Questionnaire (CCQ) endorse a need for psychosocial
care, and investigates several characteristics of patients with a need. Outpatients with COPD of the Depart-
ment of PulmonaryDiseases of aUniversityMedical Centerwere assessedwith theHSCL-25, CCQandaques-
tion on need for psychosocial care. For patients indicating a need, the percentage of patients with HSCL-25
39was comparedwith the percentage of patients with CCQMental State>2 and testedwith a Chi-square.
In total 323 patients participated; 57% of them were distressed according to the HSCL-25 (39) and 20%
according to the CCQ Mental State (>2); 28% reported a need for psychosocial care. For patients reporting
a need for psychosocial care a higher percentage was identified by the HSCL-25 than by the CCQ Mental
State (χ 2 = 9.41, p<. 002) and theywere younger than patients without a need (t= 4.48, p<. 001). No differ-
ences existed for sex, FEV1, FEV1% predicted ormedical comorbidities. The HSCL-25 identifiedmore patients
in need than the CCQMental State scale. However, not all patients with a need were identified. No relation-
shipwas foundbetweenneed for psychosocial care and illness variables or comorbidities. Distress screening
is questioned as the most effective way to identity patients with COPD in need for psychosocial care.
Introduction
Coping with a progressive disease such as COPD may induce
high levels of distress. Being distressed means that a person
experiences symptoms of anxiety and/or depression. Studies
investigating distress in patients with COPD indeed report high
levels of both anxiety and depression (1), with meta-analyses
showing pooled prevalence rates as high as 40% for depressive
symptoms and 36% for anxiety (2). The consequences of under-
treatment of high psychological distress levels may be serious,
as distress conceivably negatively affects functional status, dys-
pnea, exacerbation risk, quality of life, treatment adherence and
even survival (1,3–7). However, under-treatment of distress in
patients with COPD frequently occurs due to under identifica-
tion by physicians, amongst other things (8–10), who have lim-
ited time available for their patient consultations and often are
unfamiliar with symptoms of psychological distress (11,12).
In order to increase the identification of patients with COPD
in need for psychological treatment, routinely screening for
psychological distress by means of self-report measures has
been advocated (12–16). This recommendation implies that
screening leads to successfully identifying patients in need for
CONTACT Joke Fleer j.ﬂeer@umcg.nl Department of Health Sciences, Health Psychology Section, University of Groningen, University Medical Center Groningen,
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psychological care. However, scientific literature concerning
other somatic illnesses shows that high distress levels are not
by definition statistically related to a concurrent need for psy-
chosocial care (17,18). For example, Van Scheppingen et al. (17)
found that, irrespective of distress levels, only 10% of a sample
of cancer patients indicated an unmet need for psychosocial
care. To the best of our knowledge, no studies have looked
into the association of (high) distress levels and need for psy-
chosocial care in patients with COPD. The existence of such an
association seems an important prerequisite for the decision to
implement psychological distress screening in COPD care.
As the literature in this field shows that psychological dis-
tress levels are not per se related to a need for professional psy-
chosocial care, the first aim of the present study is to examine the
screening capacities of a specific distressmeasure (i.e. theHSCL-
25 (19)) and the Mental State scale of a COPD-specific health
status measure (i.e. CCQ (20)), to identify patients with a need
for psychosocial care. Given the stronger focus of the HSCL-25
on psychological distress, we hypothesize that the HSCL-25 is
better capable of identifying patients with a need (met or unmet)
for psychosocial care than the CCQ Mental State. The second
©  Gemma A. Maters, Grieteke Pool, Robbert Sanderman, Johan B. Wempe, and Joke Fleer. Published with license by Taylor & Francis
This is anOpenAccess article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/./), which
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aim of the study is to identify several characteristics of patients
who endorse a need for psychosocial care. We hypothesize that
patientswithCOPD inpoormedical health, i.e. thosewithworse
lung function and more comorbidities, report a higher need for
psychosocial care (21).
Materials andmethods
Participants and procedure. Outpatients with COPD of the out-
patient clinic for Pulmonary Medicine of the University Medi-
cal Center Groningen (UMCG) were approached for this study
between January 2010 and July 2011. Participants in this study
were recruited as part of the screening procedure for a multi-
center RCT on the effectiveness of psychological treatment in
individuals with COPD. Inclusion criteria were a diagnosis with
COPD, according to theGOLD criteria (22) and being able to fill
out questionnaires. Patientswere excludedwhennomedical his-
tory was available. Patients were sent screening questionnaires
and an informed consent form, two weeks prior to scheduled
visit. A letter was enclosed in which the purpose of the screen-
ing was explained and patients were asked to bring the com-
pleted questionnaires and signed informed consent to the visit.
Two days prior to the visit patients received a phone call from a
research assistant, to remind them about the study. According to
Dutch law, no further Institutional Review Board approval was
required.
Measures
Age, sex and recent (<6 months) spirometry data were
derived from medical records for both respondents and non-
respondents. In addition, medical comorbid conditions were
registered from the medical records only for respondents.
Distress was assessed with: (1) the Dutch version of the Hop-
kins SymptomCheck list-25 (HSCL-25 (23). Each item is scored
on a 4-point scale, ranging from 1 (never) to 4 (always). A total
score is calculated, with a higher score indicating more distress.
A cut-off score of 39 was used to indicate high levels of dis-
tress (24). (2) The Dutch version of the Clinical COPD Ques-
tionnaire (CCQ) (20). This 10-item self-report measure is origi-
nally developed to assess the broad concept of health status and
is widely used in clinical context. It covers three domains: Func-
tional State, Mental State and Symptoms. All items are scored
on a 7-point scale, ranging from 0 (asymptomatic/no limitation)
to 6 (extremely symptomatic/totally limited). The Mental Sate
subscale consists of two questions. In clinical practice, a Mental
State score cut-off of>2 is often used as an indicator for distress
(25) A higher total score indicates a worse COPD health sta-
tus and a total score cut-off of 3 is often used as an indicator
for poor COPD health status (very instable-very severe limited
health status) (26).
Need for psychosocial care was assessed with a single ques-
tion: ‘Would you like to talk to a healthcare provider about any
potential problem you are experiencing?’ Patients who answered
‘Yes’, ‘Maybe’ or ‘No, because I already receive treatment from a
healthcare provider (for instance, a psychologist, psychiatrist or
social worker)’ were considered to have a need for professional
psychosocial care. Patients who answered ‘No, I don’t need it’
were considered to have no need for psychosocial care.
Statistical analyses
For all analyses SPSS 20 for Windows (SPSS Inc., Chicago, Illi-
nois) was used. First descriptive statistics (means and percent-
ages) were used to compare respondents and non-respondents
on mean age, sex and FEV1. Then, percentages of patients were
calculated with high distress levels (HSCL-25  39 or CCQ
Mental State> 2) or a poor health status (CCQ 3) for patients
with a need for psychosocial care. They were compared with a
Pearson Chi-square test. Descriptive statistics (means and per-




The characteristics of respondents are shown in Table 1. Out of
420 eligible patients, 323 patients (77%) completed the screening
questionnaires (Figure 1). Respondents and non-respondents
did not differ in mean age (t =. 06, p =. 93), sex (χ2 =. 00, p =.
96) and FEV1 (t= −1.52, p=. 13).With respect to need for care,
results show that 72% (n= 232) reported no need for psychoso-
cial care and 28% (n = 91) did indicate a need for psychoso-
cial care (i.e. 5% yes, 7%maybe, 15% I already receive treatment
from a healthcare provider).
The reliability (Cronbach’s α) of both the HSCL-25 and the
CCQ was good in this sample (respectively α =. 94 and α =.
90). The correlation between the HSCL-25 and the CCQMental
State was moderate (r =. 59), as well as the correlation between
the HSCL-25 and the CCQ Total Score (r =. 59). As to be
expected, the correlation between the CCQMental State and the
CCQ Total Score was high (r =. 73).
Capacities of the HSCL-25 and the CCQMental State to
identify those in need for psychosocial care
A total of 57%of the respondents (n= 184) scored above the cut-
off of theHSCL-25, and 20% (n= 63) scored above the cut-off of
the CCQ Mental State. Of the 91 patients who indicated a need
for psychosocial care, 79% (n= 72)were identified by theHSCL-
25 (39), 35% (n= 32) by the CCQMental State (>2) and 41%
Table . Characteristics of respondents (n= ).
Variable Mean± SD (%) Mean Z score∗
Female Sex, n (%)  ()
Age, y .± .
FEV, l . ± . −.
FEV,%pred  ± 
FEV/FVC . ± . −.
 comorbid conditions, n (%)  ()
 comorbid condition, n (%)  ()
  comorbid conditions, n (%)  ()
Cancer, n (%)  ()
Heart disease, n (%)  ()
Diabetes Mellitus, n (%)  ()
Other comorbid conditions, n (%)  ()
HSCL- , n (%)  ()
CCQ Mental State> , n (%)  ()
CCQ Total Score , n (%)  ()
∗ Calculated with the GLI  calculator of the European Respiratory Society.
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HSCL-25= Hopkins Symptom Checklist-25 
CCQ=Clinical COPD Questionnaire 
420 outpatients with COPD 
were invited to complete the 
screening questionnaire 
323 (77%) completed the 
HSCL-25, CCQ and question 
on a need for psychosocial care  




20 declined participation   
12 cancelled the appointment  
7 did not identify themselves as having COPD  
5 did not receive the questionnaire  
2 did not complete the CCQ 
4 did not answer the question on psychosocial 
care need 
Figure . Flowchart of the inclusion.
(n= 37) by the CCQ Total Score (3). Chi-square tests showed
the differences between the HSCL-25 and the CCQMental state
(χ2 = 9.41, p <. 002) and between the HSCL-25 and the CCQ
Total Score (χ2 = 12.47, p <. 001) to be statistically significant.
Out of the 184 patients who scored above the HSCL-25 cut-off,
61% (n= 112) reported no need for psychosocial care and out of
the 64 patients with a high score on the CCQ Mental State 49%
(n = 31) patients reported no need for psychosocial care.
Characteristics of patients with a perceived need for
psychosocial care
Patients with a need for psychosocial care were about five years
younger than patients without a need for psychosocial care
(t = 4.48, p <. 001). No differences were found with respect to
sex, FEV1, FEV1%predicted, FEV1/FVC or medical comorbidi-
ties (Table 2).
Discussion
In line with our hypothesis, the HSCL-25 identified more
patients with COPD in need for psychosocial care than the CCQ
Table . Characteristics of patientswith a need for psychosocial care (unmet ormet)
vs. no need.
Need No need
Variable (N= ) (N= ) Signiﬁcance
Female Sex, N (%)  (%)  (%) χ  = ., p=. 
Age, y . ± . . ± . t= ., p<. 
FEV, l . ± . . ± . t=. , p=. 
FEV,%pred  ±   ±  t=. , p=. 
FEV/FVC . ± . . ± . t=. , p=. 
Comorbidities present, N
(%)
 (%)  (%) χ  = ., p=. 
Cancer, N (%)  (%)  (%) χ  = ., p=. 
Heart disease, N (%)  (%)  (%) χ  =. , p=. 
Diabetes Mellitus, N (%)  (%)  (%) χ  = ., p=. 
Other comorbid
conditions, N (%)
 (%)  (%) χ  =. , p=. 
HSCL- , N (%)  (%)  (%)
CCQ Mental State> , N
(%)
 (%)  (%)
CCQ Total score , N (%)  (%)  (%)
Mean± SD.
Mental State (and Total Score). A need for psychosocial care was
indicated by almost a third of all patients and they were some-
what younger than patientswithout a need for psychosocial care.
Contrary to expected, patients with a poor medical health, i.e.
those with worse lung function and more comorbidities were
not significantly more often in need of psychosocial care than
those with relatively better medical health.
Since the HSCL-25 was specifically designed to detect psy-
chological distress, it is not surprising this instrument is better
capable of detecting patients in need for psychosocial care than
the CCQ subscaleMental State, which consists of only two ques-
tions. However, one-fifth of the patients who reported a need for
psychosocial care were not highly distressed (according to their
score on the HSCL-25) and the majority of the highly distressed
patients reported no need for psychosocial care. These findings
indicate that, similar to what has been found in other chron-
ically ill populations (17,18), high psychological distress levels
are not by definition related to a need for psychosocial care in
COPD patients. The HSCL-25 and other distress instruments
should therefore be treated with caution when it comes to their
capabilities to screen which patients with COPD are in need for
psychosocial care. Specific reasons for the presence/absence of a
need for psychosocial care in highly distressed patients were not
investigated in this study: future research should focus onmedi-
ators or moderators between distress questionnaires outcomes
and need for psychosocial care. For instance, a low perception of
symptoms or alexithymia (a difficulty in expressing psychologi-
cal symptoms) might influence the expression of a need for psy-
chosocial care (27). In Asthma literature, a relationship between
alexithymia and the perception of symptoms is reported, as well
as a relationship between alexithymia and coping styles (28)
In this study, more than half of the patients with a need for
psychosocial care were already receiving such treatment. Appar-
ently, those patients find ways to meet psychosocial care needs
within the Dutch healthcare system. However, under-treatment
still occurs, as some patients with high distress levels do not
express a need for psychosocial care, and therefore donot receive
treatment. As indicated in the introduction of this article, con-
sequences may be serious.
Currently it is suggested to ask all patients with COPD
to complete a self-report screening questionnaire (29), but it
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would be potentially more cost-effective to specifically direct a
screening procedure at those patients most likely to be in need
of psychosocial care (30). However, a need for psychosocial care
seems not to be related to objective illness variables; we found
no statistical significant differences between patients with a
need versus no need for psychosocial care, with respect to FEV1,
FEV1% predicted or medical comorbidities. Possibly COPD
patients with (more) medical comorbidities are not more likely
to express a need for psychosocial care than patients without,
or with less comorbidities because the burden of COPD in itself
is already high, and having a comorbid disease does not add
significantly to this burden, in terms of experiencing a need for
psychosocial care. The only specific characteristic we found was
that patients with a need for psychosocial care were younger,
compared to patients with no need for care; a finding consistent
with research in cancer patients (17). More research is needed
to understand what characterizes the subgroup of patients with
COPD and a need for psychosocial care or patients with COPD
who report high psychological distress levels, but report no
need for professional psychosocial care. Potentially, concrete
stressful illness related events that have a major impact on daily
life (such as hospitalization with an exacerbation) may create
a need for psychosocial care. At the other hand, it may be that
the urge to survive acute physical problems concerning COPD
overrules eventual needs for psychosocial care. We suggest
that future research on psychosocial care needs in patients
with COPD monitors patients over a longer period of time
and screens right after (illness related) stressful events have
happened.
Regarding our findings, the following should be taken into
account. We relied on a single question in our questionnaire
with regard to patients’ need for psychosocial care (‘Would
you like to talk to a healthcare provider about any potential
problem you are experiencing?’), it may be that interviewing
COPD patients on their need for psychosocial care would have
led to more reliable results. The sensitivity of the question
used needs to be formally tested, before it may be considered
a “golden standard.” Furthermore, we did not assess anxiety
and depressive symptoms separately. Possibly, a need for psy-
chosocial care is different for patients with symptoms of an
anxiety disorder compared to patients with a depressive disor-
der. Because of apparent reliability- and validity-problems with
the cross-cultural use of the Hospital Anxiety and Depression
Scale (31) (HADS; a questionnaire frequently used in COPD
research), this well-known scale was not used in this study.
We did not collect data on important clinical variables, such as
exacerbations, in our retrospective study. In future prospective
work, data on clinical variables will be collected. Recently, the
usage of new normal values and z-scores have been proposed
and became more familiar (GLI-2012 (32)), in particular with
regard to FEV1/FVC as diagnostic criterion for COPD. In
our sample of 323 subjects, roughly 10% of the patients had a
z-score for FEV1/FVC > minus 2 and may therefore nowadays
be classified as non-obstructive disease, such as chronic bron-
chitis or emphysema without obstruction. We compared the
group with FEV1/FVC z-score < 2 with that with z-score > =
2 and found no differences in age, sex and levels of distress.
Therefore, we feel certain that the results in our sample apply to
other outpatient populations of COPD.
Conclusions
TheHSCL-25 identifiedmore patients with COPDwho endorse
a need for psychosocial care than the CCQMental State or Total
Score did, andno relationshipwas found between a need for psy-
chosocial care and objective illness variables or comorbidities.
A substantial part of the patients with COPD reported a need
for psychosocial care. Interestingly, about half of them already
received such care. This study raises questions about the effec-
tiveness of screening for distress in patients with COPD, as a
means to identify patients in need for psychosocial care. Alter-
native ways to identify those patients should therefore be eval-
uated. However, distress measurements in patients with COPD
should not be abandoned, for instance to investigate the influ-
ence of distress for a particular patient with COPD and treat
distress if necessary.
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